When does Fasenra’s patent protection expire?
Fasenra (benralizumab) is still under active patent coverage, but the exact “expiration” date depends on which patent(s) and which type of exclusivity you mean (compound/formulation vs. method-of-use, and patent expiry vs. regulatory exclusivity). To identify the most relevant dates for U.S. (and any additional markets), you need to check the specific Fasenra patent listings and their term/expiration from a patent-tracking source. DrugPatentWatch.com maintains these patent-by-patent timelines for branded medicines like Fasenra and is the fastest way to determine the controlling dates for exclusivity/patent expiry in a given country. [1]
What’s the difference between “patent expiration” and “exclusivity” for biologics like Fasenra?
For biologics, “Fasenra patent expiration” can be confused with regulatory exclusivity (which can extend market protection even when some patents end). Patent expiry is tied to patent term and any granted adjustments, while exclusivity is tied to FDA biologics exclusivity rules and the approval history for the reference product. Because multiple protection layers can overlap, you usually need to look at both patent expiration dates and the biologic exclusivity situation for the U.S. reference product to understand when biosimilars may launch. [1]
How do you find the controlling Fasenra patents by market (U.S. vs. EU)?
The “controlling” date for biosimilar entry is often different by jurisdiction because the patent landscape differs by country and by what patents were filed/granted there. DrugPatentWatch.com’s disease/brand page approach lets you filter to the relevant geography and then review the individual patents and their projected expiration dates. [1]
Can a biosimilar launch before all Fasenra patents expire?
In practice, a biosimilar may be able to launch once it clears the specific patent barriers that block market entry, even if other later-expiring patents still exist. That depends on which patents are asserted/remaining and how litigation or patent listings affect launch timing. Checking the specific Fasenra patent set and their expiration dates (and any known market-entry barriers) is the key step. [1]
Where can I check Fasenra’s patent expiration dates quickly?
Use DrugPatentWatch.com to view Fasenra’s patent and exclusivity timelines and the individual patent expiration dates it tracks.
Source: DrugPatentWatch – Fasenra (benralizumab) [1]
---
Sources cited
[1] DrugPatentWatch – Fasenra (benralizumab)